Glycine

Glycine

SCHEMBL246859

CO.NCC(=O)O.NCC(=O)O.NCC(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.83
SLC6A9 P48067 1/20 0.83
OR51E2 Q9H255 1/20 0.83
GABRR1 P24046 4/20 0.47
FFAR3 O14843 2/20 0.47
LMNA P02545 5/20 0.42
TSHR P16473 5/20 0.42
HDAC3 O15379 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
THRB P10828 2/20 0.42
BLM P54132 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
GABRR3 A8MPY1 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABBR2 O75899 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL3384608 1.00
Glycine SCHEMBL27836964 0.96
Glycine SCHEMBL29220903 0.96
Glycine SCHEMBL474856 0.92
Glycine SCHEMBL28317820 0.92
Glycine SCHEMBL6675874 0.91 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1FFAR3
Glycine SCHEMBL93765 0.91 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1FFAR3
Glycine SCHEMBL2116443 0.91
Glycine SCHEMBL391786 0.91 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1FFAR3
Glycine SCHEMBL3640989 0.91 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12004537-B2 Compositions comprising fabaceae family plant components, processes of preparation and uses thereof VIRENTIA INNOVATION INC. (CA) 2024-06-11 US disclosed
US-20240133904-A1 MONOCLONAL ANTIBODY AGAINST D-DIMER AND DIAGNOSIS AGENT FOR DETECTING D-DIMER, CROSSLINKED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMER BY USING THE ANTIBODY PRINCETON BIOMEDITECH CORPORATION (US) 2024-04-25 US disclosed
WO-2024033684-A1 COMPOSITIONS, METHODS AND USES OF EXTRACELLULAR VESICLES OF GIARDIA SPP UNIVERSIDADE DE COIMBRA (PT) 2024-02-15 WO disclosed
US-20240000107-A1 COMPOSITIONS COMPRISING FABACEAE FAMILY PLANT COMPONENTS, PROCESSES OF PREPARATION AND USES THEREOF VIRENTIA INNOVATION INC. (CA) 2024-01-04 US disclosed
CN-116769019-B ASFVp30 protein monoclonal antibody and application thereof 河北农业大学 2023-12-15 CN disclosed
CN-115029351-B Application of shRNA or BACH 1-deleted macrophage-derived EVs in preparation of medicine for treating hypertension 江南大学 2023-12-08 CN disclosed
CN-116769019-A ASFVp30 protein monoclonal antibody and application thereof 河北农业大学 2023-09-19 CN disclosed
US-11578108-B2 Amphiphysin-I mutant having anti-senescence activity and use thereof Chungbuk National University Industrial-Academic Cooperation Foundation (KR) 2023-02-14 US disclosed
CN-115029351-A Application of shRNA or BACH1 deletion macrophage-derived EVs in preparation of medicine for treating hypertension 江南大学 2022-09-09 CN disclosed
US-20210093693-A1 NOVEL USE OF GIT HAVING ANTI-SENESCENCE ACTIVITY CHUNGBUK NATIONAL UNIVERSITY INDUSTRY - ACADEMIC COOPERATION FOUNDATION (KR) 2021-04-01 US disclosed
US-5510241-A USING MONOCLONAL ANTIBODIES THE MINISTER OF AGRICULTURE, FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITIAN AND NORTHERN IRELAND (GB) 1996-04-23 US disclosed
WO-1995032430-A2 ASSAY FOR PATHOGENICITY OF ANTI-DNA ANTIBODIES OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1995-11-30 WO disclosed
WO-1995022611-A2 METHODS AND COMPOSITIONS FOR STIMULATING BONE CELLS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1995-08-24 WO disclosed
EP-0551325-A1 METHOD OF TESTING FOR SALMONELLA The Minister of Agriculture, Fisheries & Food in Her Britannic Majesty's Government of the United Kingdom and Northern Ireland (GB) 1993-07-21 EP disclosed
CN-1019133-B MONOCLONAL ANTIBODIES TO PSEUDOMONAS AERUGINOSA FLAGELLA GENETIC SYSTEMS CORP (US) 1992-11-18 CN disclosed
WO-1992006197-A1 METHOD OF TESTING FOR SALMONELLA THE MINISTER FOR AGRICULTURE, FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) 1992-04-16 WO disclosed
US-4895804-A IMMUNOLOGY UNIVERSITY OF MINNESOTA (US) 1990-01-23 US disclosed
US-4834976-A Monoclonal antibodies to pseudomonas aeruginosa flagella GENETIC SYSTEMS CORPORATION (US) 1989-05-30 US disclosed
CN-87104581-A The monoclonal antibody of resisting pseudomonas aeruginosa flagellum 1988-09-21 CN disclosed
US-4755460-A Bovine antigen glycoprotein, related antibody, and use in detection of pregnancy in cattle THE REGENTS OF THE UNIV. OF MINNESOTA (US) 1988-07-05 US disclosed